Back
Arvinas 10K Form
Sell
41
ARVN
Arvinas
Last Price:
22.68
Seasonality Move:
71.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-04 | 10Q | ARVN/Arvinas Quarterly |
| 2020-04-28 | 10Q | ARVN/Arvinas Quarterly |
| 2020-03-16 | 10K | ARVN/Arvinas Annual |
| 2019-11-04 | 10Q | ARVN/Arvinas Quarterly |
| 2019-08-05 | 10Q | ARVN/Arvinas Quarterly |
| 2019-05-09 | 10Q | ARVN/Arvinas Quarterly |
Receive ARVN News And Ratings
See the #1 stock for the next 7 days that we like better than ARVN
ARVN Financial Statistics
Sales & Book Value
| Annual Sales: | $78.5M |
|---|---|
| Cash Flow: | $-128.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.53 |
| Price / Book: | 2.72 |
Profitability
| EPS (TTM): | -4.67000 |
|---|---|
| Net Income (TTM): | $-308.6M |
| Gross Margin: | -- |
| Return on Equity: | -52.97% |
| Return on Assets: | -25.62% |
Arvinas Earnings Forecast
Key Arvinas Financial Ratios
- The Research & Development expenses have been 483.69% of Revenue.
- The Interest Expense is -0.05% of Operating Income.
- The Net Earning history of ARVN is -467.90% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 1 years.
Arvinas Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ARVN |
| CUSIP: | 04335A |
| Website: | arvinas.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.17 |
| Quick Ratio: | 4.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |